Global Biopharmaceuticals Market Size, Status and Forecast 2023

Report ID: 1234924 | Published Date: Jan 2025 | No. of Page: 128 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Biopharmaceuticals Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Monoclonal Antibodies
        1.2.3 Interferon
        1.2.4 Colony-Stimulating Factor
        1.2.5 Erythropoietin
        1.2.6 Insulin
        1.2.7 Vaccines
        1.2.8 Growth Hormones
        1.2.9 Others
    1.3 Market by Application
        1.3.1 Global Biopharmaceuticals Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Tumor
        1.3.3 Diabetes
        1.3.4 Cardiovascular
        1.3.5 Hemophilia
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Biopharmaceuticals Market Perspective (2016-2027)
    2.2 Biopharmaceuticals Growth Trends by Regions
        2.2.1 Biopharmaceuticals Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Biopharmaceuticals Historic Market Share by Regions (2016-2021)
        2.2.3 Biopharmaceuticals Forecasted Market Size by Regions (2022-2027)
    2.3 Biopharmaceuticals Industry Dynamic
        2.3.1 Biopharmaceuticals Market Trends
        2.3.2 Biopharmaceuticals Market Drivers
        2.3.3 Biopharmaceuticals Market Challenges
        2.3.4 Biopharmaceuticals Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Biopharmaceuticals Players by Revenue
        3.1.1 Global Top Biopharmaceuticals Players by Revenue (2016-2021)
        3.1.2 Global Biopharmaceuticals Revenue Market Share by Players (2016-2021)
    3.2 Global Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Biopharmaceuticals Revenue
    3.4 Global Biopharmaceuticals Market Concentration Ratio
        3.4.1 Global Biopharmaceuticals Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceuticals Revenue in 2020
    3.5 Biopharmaceuticals Key Players Head office and Area Served
    3.6 Key Players Biopharmaceuticals Product Solution and Service
    3.7 Date of Enter into Biopharmaceuticals Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Biopharmaceuticals Breakdown Data by Type
    4.1 Global Biopharmaceuticals Historic Market Size by Type (2016-2021)
    4.2 Global Biopharmaceuticals Forecasted Market Size by Type (2022-2027)

5 Biopharmaceuticals Breakdown Data by Application
    5.1 Global Biopharmaceuticals Historic Market Size by Application (2016-2021)
    5.2 Global Biopharmaceuticals Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Biopharmaceuticals Market Size (2016-2027)
    6.2 North America Biopharmaceuticals Market Size by Type
        6.2.1 North America Biopharmaceuticals Market Size by Type (2016-2021)
        6.2.2 North America Biopharmaceuticals Market Size by Type (2022-2027)
        6.2.3 North America Biopharmaceuticals Market Size by Type (2016-2027)
    6.3 North America Biopharmaceuticals Market Size by Application
        6.3.1 North America Biopharmaceuticals Market Size by Application (2016-2021)
        6.3.2 North America Biopharmaceuticals Market Size by Application (2022-2027)
        6.3.3 North America Biopharmaceuticals Market Size by Application (2016-2027)
    6.4 North America Biopharmaceuticals Market Size by Country
        6.4.1 North America Biopharmaceuticals Market Size by Country (2016-2021)
        6.4.2 North America Biopharmaceuticals Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Biopharmaceuticals Market Size (2016-2027)
    7.2 Europe Biopharmaceuticals Market Size by Type
        7.2.1 Europe Biopharmaceuticals Market Size by Type (2016-2021)
        7.2.2 Europe Biopharmaceuticals Market Size by Type (2022-2027)
        7.2.3 Europe Biopharmaceuticals Market Size by Type (2016-2027)
    7.3 Europe Biopharmaceuticals Market Size by Application
        7.3.1 Europe Biopharmaceuticals Market Size by Application (2016-2021)
        7.3.2 Europe Biopharmaceuticals Market Size by Application (2022-2027)
        7.3.3 Europe Biopharmaceuticals Market Size by Application (2016-2027)
    7.4 Europe Biopharmaceuticals Market Size by Country
        7.4.1 Europe Biopharmaceuticals Market Size by Country (2016-2021)
        7.4.2 Europe Biopharmaceuticals Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Biopharmaceuticals Market Size (2016-2027)
    8.2 Asia-Pacific Biopharmaceuticals Market Size by Type
        8.2.1 Asia-Pacific Biopharmaceuticals Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Biopharmaceuticals Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Biopharmaceuticals Market Size by Type (2016-2027)
    8.3 Asia-Pacific Biopharmaceuticals Market Size by Application
        8.3.1 Asia-Pacific Biopharmaceuticals Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Biopharmaceuticals Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Biopharmaceuticals Market Size by Application (2016-2027)
    8.4 Asia-Pacific Biopharmaceuticals Market Size by Region
        8.4.1 Asia-Pacific Biopharmaceuticals Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Biopharmaceuticals Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Biopharmaceuticals Market Size (2016-2027)
    9.2 Latin America Biopharmaceuticals Market Size by Type
        9.2.1 Latin America Biopharmaceuticals Market Size by Type (2016-2021)
        9.2.2 Latin America Biopharmaceuticals Market Size by Type (2022-2027)
        9.2.3 Latin America Biopharmaceuticals Market Size by Type (2016-2027)
    9.3 Latin America Biopharmaceuticals Market Size by Application
        9.3.1 Latin America Biopharmaceuticals Market Size by Application (2016-2021)
        9.3.2 Latin America Biopharmaceuticals Market Size by Application (2022-2027)
        9.3.3 Latin America Biopharmaceuticals Market Size by Application (2016-2027)
    9.4 Latin America Biopharmaceuticals Market Size by Country
        9.4.1 Latin America Biopharmaceuticals Market Size by Country (2016-2021)
        9.4.2 Latin America Biopharmaceuticals Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Biopharmaceuticals Market Size (2016-2027)
    10.2 Middle East & Africa Biopharmaceuticals Market Size by Type
        10.2.1 Middle East & Africa Biopharmaceuticals Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Biopharmaceuticals Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Biopharmaceuticals Market Size by Type (2016-2027)
    10.3 Middle East & Africa Biopharmaceuticals Market Size by Application
        10.3.1 Middle East & Africa Biopharmaceuticals Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Biopharmaceuticals Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Biopharmaceuticals Market Size by Application (2016-2027)
    10.4 Middle East & Africa Biopharmaceuticals Market Size by Country
        10.4.1 Middle East & Africa Biopharmaceuticals Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Biopharmaceuticals Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Details
        11.1.2 Roche Business Overview
        11.1.3 Roche Biopharmaceuticals Introduction
        11.1.4 Roche Revenue in Biopharmaceuticals Business (2016-2021)
        11.1.5 Roche Recent Development
    11.2 Amgen
        11.2.1 Amgen Company Details
        11.2.2 Amgen Business Overview
        11.2.3 Amgen Biopharmaceuticals Introduction
        11.2.4 Amgen Revenue in Biopharmaceuticals Business (2016-2021)
        11.2.5 Amgen Recent Development
    11.3 AbbVie
        11.3.1 AbbVie Company Details
        11.3.2 AbbVie Business Overview
        11.3.3 AbbVie Biopharmaceuticals Introduction
        11.3.4 AbbVie Revenue in Biopharmaceuticals Business (2016-2021)
        11.3.5 AbbVie Recent Development
    11.4 Sanofi-Aventis
        11.4.1 Sanofi-Aventis Company Details
        11.4.2 Sanofi-Aventis Business Overview
        11.4.3 Sanofi-Aventis Biopharmaceuticals Introduction
        11.4.4 Sanofi-Aventis Revenue in Biopharmaceuticals Business (2016-2021)
        11.4.5 Sanofi-Aventis Recent Development
    11.5 Johnson & Johnson
        11.5.1 Johnson & Johnson Company Details
        11.5.2 Johnson & Johnson Business Overview
        11.5.3 Johnson & Johnson Biopharmaceuticals Introduction
        11.5.4 Johnson & Johnson Revenue in Biopharmaceuticals Business (2016-2021)
        11.5.5 Johnson & Johnson Recent Development
    11.6 Pfizer
        11.6.1 Pfizer Company Details
        11.6.2 Pfizer Business Overview
        11.6.3 Pfizer Biopharmaceuticals Introduction
        11.6.4 Pfizer Revenue in Biopharmaceuticals Business (2016-2021)
        11.6.5 Pfizer Recent Development
    11.7 Novo Nordisk
        11.7.1 Novo Nordisk Company Details
        11.7.2 Novo Nordisk Business Overview
        11.7.3 Novo Nordisk Biopharmaceuticals Introduction
        11.7.4 Novo Nordisk Revenue in Biopharmaceuticals Business (2016-2021)
        11.7.5 Novo Nordisk Recent Development
    11.8 Eli Lilly
        11.8.1 Eli Lilly Company Details
        11.8.2 Eli Lilly Business Overview
        11.8.3 Eli Lilly Biopharmaceuticals Introduction
        11.8.4 Eli Lilly Revenue in Biopharmaceuticals Business (2016-2021)
        11.8.5 Eli Lilly Recent Development
    11.9 Novartis
        11.9.1 Novartis Company Details
        11.9.2 Novartis Business Overview
        11.9.3 Novartis Biopharmaceuticals Introduction
        11.9.4 Novartis Revenue in Biopharmaceuticals Business (2016-2021)
        11.9.5 Novartis Recent Development
    11.10 Merck
        11.10.1 Merck Company Details
        11.10.2 Merck Business Overview
        11.10.3 Merck Biopharmaceuticals Introduction
        11.10.4 Merck Revenue in Biopharmaceuticals Business (2016-2021)
        11.10.5 Merck Recent Development
    11.11 Sun
        11.11.1 Sun Company Details
        11.11.2 Sun Business Overview
        11.11.3 Sun Biopharmaceuticals Introduction
        11.11.4 Sun Revenue in Biopharmaceuticals Business (2016-2021)
        11.11.5 Sun Recent Development
    11.12 3sbio
        11.12.1 3sbio Company Details
        11.12.2 3sbio Business Overview
        11.12.3 3sbio Biopharmaceuticals Introduction
        11.12.4 3sbio Revenue in Biopharmaceuticals Business (2016-2021)
        11.12.5 3sbio Recent Development
    11.13 Changchun High Tech
        11.13.1 Changchun High Tech Company Details
        11.13.2 Changchun High Tech Business Overview
        11.13.3 Changchun High Tech Biopharmaceuticals Introduction
        11.13.4 Changchun High Tech Revenue in Biopharmaceuticals Business (2016-2021)
        11.13.5 Changchun High Tech Recent Development
    11.14 CP Guojian
        11.14.1 CP Guojian Company Details
        11.14.2 CP Guojian Business Overview
        11.14.3 CP Guojian Biopharmaceuticals Introduction
        11.14.4 CP Guojian Revenue in Biopharmaceuticals Business (2016-2021)
        11.14.5 CP Guojian Recent Development
    11.15 Biotech
        11.15.1 Biotech Company Details
        11.15.2 Biotech Business Overview
        11.15.3 Biotech Biopharmaceuticals Introduction
        11.15.4 Biotech Revenue in Biopharmaceuticals Business (2016-2021)
        11.15.5 Biotech Recent Development
    11.16 Gelgen
        11.16.1 Gelgen Company Details
        11.16.2 Gelgen Business Overview
        11.16.3 Gelgen Biopharmaceuticals Introduction
        11.16.4 Gelgen Revenue in Biopharmaceuticals Business (2016-2021)
        11.16.5 Gelgen Recent Development
    11.17 Innovent
        11.17.1 Innovent Company Details
        11.17.2 Innovent Business Overview
        11.17.3 Innovent Biopharmaceuticals Introduction
        11.17.4 Innovent Revenue in Biopharmaceuticals Business (2016-2021)
        11.17.5 Innovent Recent Development
    11.18 Dong Bao
        11.18.1 Dong Bao Company Details
        11.18.2 Dong Bao Business Overview
        11.18.3 Dong Bao Biopharmaceuticals Introduction
        11.18.4 Dong Bao Revenue in Biopharmaceuticals Business (2016-2021)
        11.18.5 Dong Bao Recent Development
    11.19 Ganlee
        11.19.1 Ganlee Company Details
        11.19.2 Ganlee Business Overview
        11.19.3 Ganlee Biopharmaceuticals Introduction
        11.19.4 Ganlee Revenue in Biopharmaceuticals Business (2016-2021)
        11.19.5 Ganlee Recent Development
    11.20 United Laboratories
        11.20.1 United Laboratories Company Details
        11.20.2 United Laboratories Business Overview
        11.20.3 United Laboratories Biopharmaceuticals Introduction
        11.20.4 United Laboratories Revenue in Biopharmaceuticals Business (2016-2021)
        11.20.5 United Laboratories Recent Development
    11.21 SANDOZ (NOVARTIS)
        11.21.1 SANDOZ (NOVARTIS) Company Details
        11.21.2 SANDOZ (NOVARTIS) Business Overview
        11.21.3 SANDOZ (NOVARTIS) Biopharmaceuticals Introduction
        11.21.4 SANDOZ (NOVARTIS) Revenue in Biopharmaceuticals Business (2016-2021)
        11.21.5 SANDOZ (NOVARTIS) Recent Development
    11.22 Teva Pharmaceutical
        11.22.1 Teva Pharmaceutical Company Details
        11.22.2 Teva Pharmaceutical Business Overview
        11.22.3 Teva Pharmaceutical Biopharmaceuticals Introduction
        11.22.4 Teva Pharmaceutical Revenue in Biopharmaceuticals Business (2016-2021)
        11.22.5 Teva Pharmaceutical Recent Development
    11.23 Hospira （Pfizer）
        11.23.1 Hospira （Pfizer） Company Details
        11.23.2 Hospira （Pfizer） Business Overview
        11.23.3 Hospira （Pfizer） Biopharmaceuticals Introduction
        11.23.4 Hospira （Pfizer） Revenue in Biopharmaceuticals Business (2016-2021)
        11.23.5 Hospira （Pfizer） Recent Development
    11.24 MYLAN
        11.24.1 MYLAN Company Details
        11.24.2 MYLAN Business Overview
        11.24.3 MYLAN Biopharmaceuticals Introduction
        11.24.4 MYLAN Revenue in Biopharmaceuticals Business (2016-2021)
        11.24.5 MYLAN Recent Development
    11.25 Sun pharma
        11.25.1 Sun pharma Company Details
        11.25.2 Sun pharma Business Overview
        11.25.3 Sun pharma Biopharmaceuticals Introduction
        11.25.4 Sun pharma Revenue in Biopharmaceuticals Business (2016-2021)
        11.25.5 Sun pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Biopharmaceuticals Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Monoclonal Antibodies
    Table 3. Key Players of Interferon
    Table 4. Key Players of Colony-Stimulating Factor
    Table 5. Key Players of Erythropoietin
    Table 6. Key Players of Insulin
    Table 7. Key Players of Vaccines
    Table 8. Key Players of Growth Hormones
    Table 9. Key Players of Others
    Table 10. Global Biopharmaceuticals Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 11. Global Biopharmaceuticals Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 12. Global Biopharmaceuticals Market Size by Regions (2016-2021) & (US$ Million)
    Table 13. Global Biopharmaceuticals Market Share by Regions (2016-2021)
    Table 14. Global Biopharmaceuticals Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 15. Global Biopharmaceuticals Market Share by Regions (2022-2027)
    Table 16. Biopharmaceuticals Market Trends
    Table 17. Biopharmaceuticals Market Drivers
    Table 18. Biopharmaceuticals Market Challenges
    Table 19. Biopharmaceuticals Market Restraints
    Table 20. Global Biopharmaceuticals Revenue by Players (2016-2021) & (US$ Million)
    Table 21. Global Biopharmaceuticals Market Share by Players (2016-2021)
    Table 22. Global Top Biopharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceuticals as of 2020)
    Table 23. Ranking of Global Top Biopharmaceuticals Companies by Revenue (US$ Million) in 2020
    Table 24. Global 5 Largest Players Market Share by Biopharmaceuticals Revenue (CR5 and HHI) & (2016-2021)
    Table 25. Key Players Headquarters and Area Served
    Table 26. Key Players Biopharmaceuticals Product Solution and Service
    Table 27. Date of Enter into Biopharmaceuticals Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)
    Table 30. Global Biopharmaceuticals Revenue Market Share by Type (2016-2021)
    Table 31. Global Biopharmaceuticals Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 32. Global Biopharmaceuticals Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 33. Global Biopharmaceuticals Market Size Share by Application (2016-2021) & (US$ Million)
    Table 34. Global Biopharmaceuticals Revenue Market Share by Application (2016-2021)
    Table 35. Global Biopharmaceuticals Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 36. Global Biopharmaceuticals Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 37. North America Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)
    Table 38. North America Biopharmaceuticals Market Size by Type (2022-2027) & (US$ Million)
    Table 39. North America Biopharmaceuticals Market Size by Application (2016-2021) (US$ Million)
    Table 40. North America Biopharmaceuticals Market Size by Application (2022-2027) & (US$ Million)
    Table 41. North America Biopharmaceuticals Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. North America Biopharmaceuticals Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Europe Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)
    Table 44. Europe Biopharmaceuticals Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Europe Biopharmaceuticals Market Size by Application (2016-2021) (US$ Million)
    Table 46. Europe Biopharmaceuticals Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Europe Biopharmaceuticals Market Size by Country (2016-2021) & (US$ Million) 
    Table 48. Europe Biopharmaceuticals Market Size by Country (2022-2027) & (US$ Million) 
    Table 49. Asia-Pacific Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)
    Table 50. Asia-Pacific Biopharmaceuticals Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Asia-Pacific Biopharmaceuticals Market Size by Application (2016-2021) (US$ Million)
    Table 52. Asia-Pacific Biopharmaceuticals Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Asia-Pacific Biopharmaceuticals Market Size by Region (2016-2021) & (US$ Million) 
    Table 54. Asia-Pacific Biopharmaceuticals Market Size by Region (2022-2027) & (US$ Million) 
    Table 55. Latin America Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)
    Table 56. Latin America Biopharmaceuticals Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Latin America Biopharmaceuticals Market Size by Application (2016-2021) (US$ Million)
    Table 58. Latin America Biopharmaceuticals Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Latin America Biopharmaceuticals Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Latin America Biopharmaceuticals Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Middle East & Africa Biopharmaceuticals Market Size by Type (2016-2021) (US$ Million)
    Table 62. Middle East & Africa Biopharmaceuticals Market Size by Type (2022-2027) & (US$ Million)
    Table 63. Middle East & Africa Biopharmaceuticals Market Size by Application (2016-2021) (US$ Million)
    Table 64. Middle East & Africa Biopharmaceuticals Market Size by Application (2022-2027) & (US$ Million)
    Table 65. Middle East & Africa Biopharmaceuticals Market Size by Country (2016-2021) & (US$ Million) 
    Table 66. Middle East & Africa Biopharmaceuticals Market Size by Country (2022-2027) & (US$ Million) 
    Table 67. Roche Company Details
    Table 68. Roche Business Overview
    Table 69. Roche Biopharmaceuticals Product
    Table 70. Roche Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 71. Roche Recent Development
    Table 72. Amgen Company Details
    Table 73. Amgen Business Overview
    Table 74. Amgen Biopharmaceuticals Product
    Table 75. Amgen Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 76. Amgen Recent Development
    Table 77. AbbVie Company Details
    Table 78. AbbVie Business Overview
    Table 79. AbbVie Biopharmaceuticals Product
    Table 80. AbbVie Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 81. AbbVie Recent Development
    Table 82. Sanofi-Aventis Company Details
    Table 83. Sanofi-Aventis Business Overview
    Table 84. Sanofi-Aventis Biopharmaceuticals Product
    Table 85. Sanofi-Aventis Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 86. Sanofi-Aventis Recent Development
    Table 87. Johnson & Johnson Company Details
    Table 88. Johnson & Johnson Business Overview
    Table 89. Johnson & Johnson Biopharmaceuticals Product
    Table 90. Johnson & Johnson Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 91. Johnson & Johnson Recent Development
    Table 92. Pfizer Company Details
    Table 93. Pfizer Business Overview
    Table 94. Pfizer Biopharmaceuticals Product
    Table 95. Pfizer Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 96. Pfizer Recent Development
    Table 97. Novo Nordisk Company Details
    Table 98. Novo Nordisk Business Overview
    Table 99. Novo Nordisk Biopharmaceuticals Product
    Table 100. Novo Nordisk Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 101. Novo Nordisk Recent Development
    Table 102. Eli Lilly Company Details
    Table 103. Eli Lilly Business Overview
    Table 104. Eli Lilly Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 105. Eli Lilly Recent Development
    Table 106. Novartis Company Details
    Table 107. Novartis Business Overview
    Table 108. Novartis Biopharmaceuticals Product
    Table 109. Novartis Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 110. Novartis Recent Development
    Table 111. Merck Company Details
    Table 112. Merck Business Overview
    Table 113. Merck Biopharmaceuticals Product
    Table 114. Merck Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 115. Merck Recent Development
    Table 116. Sun Company Details
    Table 117. Sun Business Overview
    Table 118. Sun Biopharmaceuticals Product
    Table 119. Sun Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 120. Sun Recent Development
    Table 121. 3sbio Company Details
    Table 122. 3sbio Business Overview
    Table 123. 3sbio Biopharmaceuticals Product
    Table 124. 3sbio Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 125. 3sbio Recent Development
    Table 126. Changchun High Tech Company Details
    Table 127. Changchun High Tech Business Overview
    Table 128. Changchun High Tech Biopharmaceuticals Product
    Table 129. Changchun High Tech Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 130. Changchun High Tech Recent Development
    Table 131. CP Guojian Company Details
    Table 132. CP Guojian Business Overview
    Table 133. CP Guojian Biopharmaceuticals Product
    Table 134. CP Guojian Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 135. CP Guojian Recent Development
    Table 136. Biotech Company Details
    Table 137. Biotech Business Overview
    Table 138. Biotech Biopharmaceuticals Product
    Table 139. Biotech Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 140. Biotech Recent Development
    Table 141. Gelgen Company Details
    Table 142. Gelgen Business Overview
    Table 143. Gelgen Biopharmaceuticals Product
    Table 144. Gelgen Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 145. Gelgen Recent Development
    Table 146. Innovent Company Details
    Table 147. Innovent Business Overview
    Table 148. Innovent Biopharmaceuticals Product
    Table 149. Innovent Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 150. Innovent Recent Development
    Table 151. Dong Bao Company Details
    Table 152. Dong Bao Business Overview
    Table 153. Dong Bao Biopharmaceuticals Product
    Table 154. Dong Bao Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 155. Dong Bao Recent Development
    Table 156. Ganlee Company Details
    Table 157. Ganlee Business Overview
    Table 158. Ganlee Biopharmaceuticals Product
    Table 159. Ganlee Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 160. Ganlee Recent Development
    Table 161. United Laboratories Company Details
    Table 162. United Laboratories Business Overview
    Table 163. United Laboratories Biopharmaceuticals Product
    Table 164. United Laboratories Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 165. United Laboratories Recent Development
    Table 166. SANDOZ (NOVARTIS) Company Details
    Table 167. SANDOZ (NOVARTIS) Business Overview
    Table 168. SANDOZ (NOVARTIS) Biopharmaceuticals Product
    Table 169. SANDOZ (NOVARTIS) Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 170. SANDOZ (NOVARTIS) Recent Development
    Table 171. Teva Pharmaceutical Company Details
    Table 172. Teva Pharmaceutical Business Overview
    Table 173. Teva Pharmaceutical Biopharmaceuticals Product
    Table 174. Teva Pharmaceutical Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 175. Teva Pharmaceutical Recent Development
    Table 176. Hospira （Pfizer） Company Details
    Table 177. Hospira （Pfizer） Business Overview
    Table 178. Hospira （Pfizer） Biopharmaceuticals Product
    Table 179. Hospira （Pfizer） Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 180. Hospira （Pfizer） Recent Development
    Table 181. MYLAN Company Details
    Table 182. MYLAN Business Overview
    Table 183. MYLAN BiopharmaceuticalsProduct
    Table 184. MYLAN Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 185. MYLAN Recent Development
    Table 186. Sun pharma Company Details
    Table 187. Sun pharma Business Overview
    Table 188. Sun pharma Biopharmaceuticals Product
    Table 189. Sun pharma Revenue in Biopharmaceuticals Business (2016-2021) & (US$ Million)
    Table 190. Sun pharma Recent Development
    Table 191. Research Programs/Design for This Report
    Table 192. Key Data Information from Secondary Sources
    Table 193. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Biopharmaceuticals Market Share by Type: 2020 VS 2027
    Figure 2. Monoclonal Antibodies Features
    Figure 3. Interferon Features
    Figure 4. Colony-Stimulating Factor Features
    Figure 5. Erythropoietin Features
    Figure 6. Insulin Features
    Figure 7. Vaccines Features
    Figure 8. Growth Hormones Features
    Figure 9. Others Features
    Figure 10. Global Biopharmaceuticals Market Share by Application: 2020 VS 2027
    Figure 11. Tumor Case Studies
    Figure 12. Diabetes Case Studies
    Figure 13. Cardiovascular Case Studies
    Figure 14. Hemophilia Case Studies
    Figure 15. Others Case Studies
    Figure 16. Biopharmaceuticals Report Years Considered
    Figure 17. Global Biopharmaceuticals Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 18. Global Biopharmaceuticals Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 19. Global Biopharmaceuticals Market Share by Regions: 2020 VS 2027
    Figure 20. Global Biopharmaceuticals Market Share by Regions (2022-2027)
    Figure 21. Global Biopharmaceuticals Market Share by Players in 2020
    Figure 22. Global Top Biopharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceuticals as of 2020
    Figure 23. The Top 10 and 5 Players Market Share by Biopharmaceuticals Revenue in 2020
    Figure 24. Global Biopharmaceuticals Revenue Market Share by Type (2016-2021)
    Figure 25. Global Biopharmaceuticals Revenue Market Share by Type (2022-2027)
    Figure 26. North America Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. North America Biopharmaceuticals Market Share by Type (2016-2027)
    Figure 28. North America Biopharmaceuticals Market Share by Application (2016-2027)
    Figure 29. North America Biopharmaceuticals Market Share by Country (2016-2027)
    Figure 30. United States Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Canada Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Europe Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Europe Biopharmaceuticals Market Share by Type (2016-2027)
    Figure 34. Europe Biopharmaceuticals Market Share by Application (2016-2027)
    Figure 35. Europe Biopharmaceuticals Market Share by Country (2016-2027)
    Figure 36. Germany Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. France Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. U.K. Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Italy Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Russia Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Nordic Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Asia-Pacific Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Asia-Pacific Biopharmaceuticals Market Share by Type (2016-2027)
    Figure 44. Asia-Pacific Biopharmaceuticals Market Share by Application (2016-2027)
    Figure 45. Asia-Pacific Biopharmaceuticals Market Share by Region (2016-2027)
    Figure 46. China Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Japan Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. South Korea Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Southeast Asia Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. India Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Australia Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Latin America Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Latin America Biopharmaceuticals Market Share by Type (2016-2027)
    Figure 54. Latin America Biopharmaceuticals Market Share by Application (2016-2027)
    Figure 55. Latin America Biopharmaceuticals Market Share by Country (2016-2027)
    Figure 56. Mexico Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Brazil Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Middle East & Africa Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Middle East & Africa Biopharmaceuticals Market Share by Type (2016-2027)
    Figure 60. Middle East & Africa Biopharmaceuticals Market Share by Application (2016-2027)
    Figure 61. Middle East & Africa Biopharmaceuticals Market Share by Country (2016-2027)
    Figure 62. Turkey Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 63. Saudi Arabia Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 64. UAE Biopharmaceuticals Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 65. Roche Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 66. Amgen Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 67. AbbVie Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 68. Sanofi-Aventis Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 69. Johnson & Johnson Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 70. Pfizer Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 71. Novo Nordisk Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 72. Eli Lilly Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 73. Novartis Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 74. Merck Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 75. Sun Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 76. 3sbio Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 77. Changchun High Tech Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 78. CP Guojian Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 79. Biotech Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 80. Gelgen Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 81. Innovent Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 82. Dong Bao Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 83. Ganlee Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 84. United Laboratories Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 85. SANDOZ (NOVARTIS) Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 86. Teva Pharmaceutical Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 87. Hospira （Pfizer） Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 88. MYLAN Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 89. Sun pharma Revenue Growth Rate in Biopharmaceuticals Business (2016-2021)
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
Sun
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories
SANDOZ (NOVARTIS)
Teva Pharmaceutical
Hospira （Pfizer）
MYLAN
Sun pharma
Frequently Asked Questions
Biopharmaceuticals report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Biopharmaceuticals report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Biopharmaceuticals report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Powertrain Testing

Powertrain Testing market is segmented by company, region (country), by Type, and by Application. ... Read More

Electronic Cable

Electronic Cable market is segmented by company, region (country), by Type, and by Application. P ... Read More

DNA Forensic

DNA Forensic market is segmented by company, region (country), by Type, and by Application. Playe ... Read More